-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Prostate cancer (PCa) is the second most common cancer among men worldwide.
Prostate cancer (PCa) is the second most common cancer among men worldwide.
Therefore, the study aims to explore the correlation between the level of estrogen in urine and the clinical outcome of patients.
The study aims to explore the correlation between the level of estrogen in urine and the clinical outcome of patients.
The researchers collected urine samples from patients before radical prostatectomy (RP) in the prospective multi-institution PROCURE cohort, and set up a discovery cohort (n=259) and a verification cohort (n=253) two cohort studies .
The biotransformation model of estrogen and its related derivatives
The biotransformation model of estrogen and its related derivativesThe results showed that the median follow-up time for the discovery and verification cohorts were 7.
Correlation of estrogen in urine of patients with prostate cancer
Correlation of estrogen in urine of patients with prostate cancerAll in all, the results of the study revealed that the levels of estriol and 16-ketoestradiol metabolites in urine are associated with a more favorable outcome for patients, while the level of 2-methoxyestrone is associated with the risk of metastasis after RP.
The results of the study revealed that urine levels of estriol and 16-ketoestradiol metabolites are associated with more favorable outcomes for patients, while 2-methoxyestrone levels are associated with increased risk of metastasis after RP Related.
org/10.
Leave a message here